Search - tctmd.com

Displaying 41 - 60 of 261

Sort: Relevancy | Date

News Daily News

Xience Cleared in Europe for 1-Month DAPT in High-Bleeding-Risk Patients

Shelley Wood

April 06, 2021

News Daily News

Invasive Approach Best for Cocaine-Linked NSTEMI, but DAPT Is Key

Michael O'Riordan

March 16, 2021

News Daily News

Site Investigators Missed Clinical Events in GLOBAL LEADERS

Michael O'Riordan

February 12, 2021

News Daily News

Primary PCI Underused but Just as Effective in Cancer Patients With STEMI

Michael O'Riordan

February 04, 2021

News Daily News

Based on Machine Learning, PRAISE Score Balances Risks in Post-ACS Care

Yael L. Maxwell

January 26, 2021

News Daily News

New Tool Helps Balance Bleeding and Thrombotic Risks After PCI

Yael L. Maxwell

January 13, 2021

News Daily News

In ISCHEMIA, Stable CAD Treatment Effect Hinged on MI Definition

Michael O'Riordan

December 11, 2020

News Conference News AHA 2020

Latest Post-DES Drug Trial Tests Aspirin Monotherapy After 1 Month of DAPT

Shelley Wood

November 15, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2020

Shelley Wood

October 30, 2020

News Conference News TCT 2020

Stent Polymer Face-off Calls Bioresorbable Coatings Into Question

Shelley Wood

October 17, 2020

News Conference News TCT 2020

Shorter DAPT Succeeds in Xience-Treated Patients at High Bleeding Risk

Caitlin E. Cox

October 15, 2020

News Daily News

Features of Complex CAD Carry Progressive Risk in PCI, Registry Confirms

Caitlin E. Cox

October 08, 2020

News Daily News

‘Aspirin-Free’ Antiplatelet Strategy Feasible After PCI, Pilot Study Suggests

Michael O'Riordan

September 18, 2020

News Daily News

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

Michael O'Riordan

September 16, 2020

News Daily News

Analysis Supports Short DAPT Followed by P2Y12 Inhibitor Monotherapy After DES PCI

L.A. McKeown

August 10, 2020

News Daily News

Polymer-Free DES Hold No Long-term Advantage: ISAR-TEST-5

Michael O'Riordan

July 07, 2020

News Industry News

CeloNova Announces Enrollment Completion of World’s First Randomized Control, 14-Day DAPT Trial

June 01, 2020

News Daily News

Clopidogrel Holds Advantage in Older NTSE ACS Patients: POPular AGE Published

Michael O'Riordan

April 27, 2020

News Conference News ACC 2020

TICO: Ticagrelor Monotherapy After 3 Months of DAPT Curbs Bleeding in Stented ACS Patients

Todd Neale

March 31, 2020

Presentation ACC 2020

Ticagrelor With or Without Aspirin in Acute Coronary Syndrome After PCI: Randomized Evaluation Of Ticagrelor Monotherapy After 3- month Dual-antiplatelet Therapy In Acute Coronary Syndrome The TICO trial

Presenter: Yangsoo Jang

March 30, 2020

Advertisement

Xience Cleared in Europe for 1-Month DAPT in High-Bleeding-Risk Patients

Invasive Approach Best for Cocaine-Linked NSTEMI, but DAPT Is Key

Site Investigators Missed Clinical Events in GLOBAL LEADERS

Primary PCI Underused but Just as Effective in Cancer Patients With STEMI

Based on Machine Learning, PRAISE Score Balances Risks in Post-ACS Care

New Tool Helps Balance Bleeding and Thrombotic Risks After PCI

In ISCHEMIA, Stable CAD Treatment Effect Hinged on MI Definition

Latest Post-DES Drug Trial Tests Aspirin Monotherapy After 1 Month of DAPT

TCTMD’s Top 10 Most Popular Stories for October 2020

Stent Polymer Face-off Calls Bioresorbable Coatings Into Question

Shorter DAPT Succeeds in Xience-Treated Patients at High Bleeding Risk

Features of Complex CAD Carry Progressive Risk in PCI, Registry Confirms

‘Aspirin-Free’ Antiplatelet Strategy Feasible After PCI, Pilot Study Suggests

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

Analysis Supports Short DAPT Followed by P2Y12 Inhibitor Monotherapy After DES PCI

Polymer-Free DES Hold No Long-term Advantage: ISAR-TEST-5

CeloNova Announces Enrollment Completion of World’s First Randomized Control, 14-Day DAPT Trial

Clopidogrel Holds Advantage in Older NTSE ACS Patients: POPular AGE Published

TICO: Ticagrelor Monotherapy After 3 Months of DAPT Curbs Bleeding in Stented ACS Patients

Ticagrelor With or Without Aspirin in Acute Coronary Syndrome After PCI: Randomized Evaluation Of Ticagrelor Monotherapy After 3- month Dual-antiplatelet Therapy In Acute Coronary Syndrome The TICO trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content